A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Clinical trial NCT07676266 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07676266
Sponsor: The Affiliated Hospital of Qingdao University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder Systemic Lupus Erythematosus Systemic Sclerosis Immune-Mediated Necrotizing Myopathy

Start date: 2026-07-01
Primary completion: 2027-11-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.